Non-linear elimination and protein binding of probenecid
- 1 January 1987
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 32 (4) , 395-401
- https://doi.org/10.1007/bf00543976
Abstract
Summary Six healthy volunteers were given probenecid 0.5, 1 and 2 g p.o. and 0.5 g i.v. The protein binding of probenecid at different concentrations in human plasma was estimated by equilibrium dialysis. The free fraction was found to increase nonlinearly with increasing total probenecid concentration, up to a maximum free fraction of 26%. The plasma concentration-time data after the oral doses were described by a one-compartment open model with first-order absorption and Michaelis-Menten elimination. The mean absorption rate constant 0.0072 min−1 was dose-independent, and the maximal rate of elimination (mean 1429 µg/min) did not differ between doses whether calculated from the total or free concentrations. The Michaelis-Menten constant decreased significantly from 67.1 to 55.5 µg/ml as the dose increased from 1 g to 2 g, while the unbound Michaelis-Menten constant remained unchanged. The elimination of probenecid after the 0.5 g dose was in the linear region of the Michaelis-Menten elimination when calculated from the total and the free concentrations. The volume of distribution increased only slightly from 9.5 to 11.4 l as the dose increased from 0.5 to 2 g, but the unbound volume of distribution decreased significantly from 164 to 99 l. Absorption was complete and was independent of the dose administered.Keywords
This publication has 28 references indexed in Scilit:
- Theophylline Pooled Michaelis-Menten Parameters (Vmax and Km) and ImplicationsClinical Pharmacokinetics, 1985
- Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Probenecid sensitive pathway of elimination of dopamine and serotonin metabolites in CSF of the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981
- Nonlinear assessment of phenytoin bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Urinary excretion of probenecid and its metabolites in humans as a function of doseJournal of Pharmaceutical Sciences, 1976
- Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation pathsJournal of Pharmacokinetics and Biopharmaceutics, 1974
- Bioavailability calculations for drugs showing simultaneous first-order and capacity-limited elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- FACTORS AFFECTING DRUG METABOLISMAnnals of the New York Academy of Sciences, 1971
- THE METABOLISM OF PROBENECID IN MANAnnals of the New York Academy of Sciences, 1971